chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient was on a stretcher and they reassured her not to worry and that some people get nervous when they see needles; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The reporter mentioned that she thinks there could be something wrong with the lot of Pfizer COVID vaccine because a lady was pulled out on a stretcher and the nurse said this really doesn't happen often and people were taken out in chairs. The patient was on a stretcher and they reassured her not to worry and that some people get nervous when they see needles. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Shortly after receiving the second vaccine shot a started to notice unusual bleeding (what I knew to be common to ITP) primarily I was getting more frequent nose bleeds that became more and more difficult to stop.  On 04/24/2021 the bleeding seemed to be really bad so I contacted my hematologist and discussed the symptoms.  He directed to to go to the nearest hospital and have my platelet count checked.  I went to Hospital in.
Information has been received from a woman in a pediatrician's office concerning a 4 year old male student with seasonal allergies who on 10/19/00 was vaccinated with a dose of varicella virus vaccine live. It was reported that on 3/2/04 the patient developed red bumps on his body, cough, fever, and itching. A diagnosis of chicken pox was made. The patient was subsequently seen by a physician. On 3/3/04, the patient's cough resolved and after several days his fever also resolved. In March 2004, the patient recovered from his chicken pox. Follow up information received on 3/30/04 contained the following adverse experiences: strep throat (3/23/04). No further information is available.
Information has been received from a county health nurse concerning a 6 year old male who on 18-JAN-2002 was vaccinated with varicella virus vaccine live (Oka/Merck). On 10-MAR-2007, the patient developed varicella, < 50 lesions. The nurse reported that an outbreak of varicella had take place in the local school district in April 2007, and this student was identified during the county health investigation. An immunization clinic was conducted in the school where students received a second dose of varicella virus vaccine live (Oka/Merck). This is one of 28 reports received from the same source. No further information is available.
I have reported this to XXXX twice but both times the report ended with XXXX stating they would investigate and get back with me. Issue: XXXX administered my 2nd dose of the Twinrix vaccine, but that dose was never recorded. 4/21/2022: I initiated the series of 3 Twinrix vaccine doses. XXXX in XXXX 7/12/2022: I was late to return and receive my 2nd dose. XXXX in XXXX around 10-11 AM. 7/13/2022: I called XXXX to inquire if I should get my 3rd dose on the original schedule (6 months from the first dose, roughly 10/21/2022) or wait 5 months after my 2nd dose (roughly 12/12/2022). The pharmacist on the phone advised me that I should wait 5 months. 12/14/2022: I returned for my 3rd dose XXXX in XXXX I was informed that there was no record of my 2nd dose. The pharmacist further informed me that he could not administer a 3rd or 2nd dose. He stated that I needed to wait 1 year from my first dose (4/21/2023) to start over. Base on my frustration that the record of the 2nd does was lost, he advised me to go back to the XXXX location to investigate the missing dose. I stated that I would, and asked him to do the same, suggesting to him that his ties with XXXX authority should offer better path of investigation than me. He agreed (seemingly reluctantly), but I never hear back from him. 12/20/2022: I called XXXX at 3:00PM to report the issue. 12/20/2022: XXXX returned my call XXXX at 6:34PM. After I gave the gentleman on the phone a complete explanation of events, he stated he would investigate and let me know what he found out. He also advised me, that the pharmacist at certain location was incorrect, and that I could pursue a 3rd dose immediately without a record of the second dose. I asked him, and he confirmed with me that he was a pharmacist. I thanked him and responded that I would very much like the record/evidence of my 2nd dose found, so that I could have a full vaccine record of the doses, in addition to my knowledge that I received all three doses. He understood and told me he would investigate and let me know.
Swelling and redness and itching in arm starting the day after vaccine it went away about a week later. Now two weeks since the vaccine the swelling redness and itchiness has come back
blood pressure high; high fever; wet; rapid heart/palpitations; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 85 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 26Feb2021 15:30 (Lot number: EL3302) as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing); "blood thinner" (unspecified if ongoing); "colon cancer", start date: 26Mar2018 (ongoing), notes: Pertinent Details: Surgery to remove colon cancer for 2 years chemotherapy to put cancer in remission; "Hypertension", start date: 1980 (ongoing), notes: Pertinent Details: HBP controlled by medications, increased diet; "Mitral valve", start date: 1980 (ongoing), notes: Pertinent Details: controlled by atenolol. Family history included: "heart disease" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL taken for cardiac disorder (ongoing); AMLODIPINE taken for hypertension (ongoing); BABY ASPIRIN taken for anticoagulant therapy (ongoing). Vaccination history included: Bnt162b2 (Dose: 1st, Date: 05Feb2021, Time: 3:30 PM, Anatomical Site of injection: left upper arm, Route of administration: Intramuscular, Batch/Lot Number: Pfizer EK4176), administration date: 05Feb2021, when the patient was 85 years old, for Covid-19 immunization. The following information was reported: HYPERTENSION (hospitalization), outcome "unknown", described as "blood pressure high"; PALPITATIONS (non-serious) with onset 2021, outcome "unknown", described as "rapid heart/palpitations"; HYPERHIDROSIS (non-serious) with onset Mar2021, outcome "unknown", described as "wet"; PYREXIA (non-serious) with onset Mar2021, outcome "unknown", described as "high fever". The patient underwent the following laboratory tests and procedures: blood pressure measurement: over 200. Additional Information: I am a heart patient and I am also in remission for colon cancer. Approximately ten days after my second Pfizer shot I woke up very early in the morning with a high fever and my groin was sobby wet. The concierge (illegible) an ambulance + before I went to the hospital, my pressure was over 200 and I began to get rapid heart palpitations a few days later my doctors and I got over that through. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021211093 same patient/drug/different event/dose
Vomiting, every 30 minutes for 6 hours Fever for 6 hours Diarrhea, 5 days Loss of appetite 3 days
Heart raced first day. As the days went on, my blood pressure became erratic, which sent me into an autonomic flare that I haven't come out of - almost a year later. In October 2021, I went to the ER: BP 149/133; HR: 59 and chest pain. No heart issues previous to shot. HR 145/100; no diagnosis other than costochondritis, which I never had.
12 hours after vaccination, developed aches, fever, headache, and chills. Fever/aches/chills ended about 12 hours later, fatigue ended 18 hours after vaccination. Ten (10) days after vaccination, developed hives that did not resolve with over the counter allergy medication, and changing areas of red, itchy skin.
Patient described pain in left arm that radiated up neck .  Patient stated  it was difficult to lift her arm  due to pain and she was unable to sleep on  her left arm. She described a lump at the injection site on her left deltoid. She denied there being any redness, hotness and red streaking  on left arm.  Patient used cold compress and self treated.
PATIENT GIVEN DOSE BY CERTIFIED INTERN, PATIENT PUT HER SWEATER BACK ON AND THEN GOT UP WALKED 3-5 STEPS AWAY AND FELL, SHE BANGED HER HEAD, HERE COLOR LOOKED PALE THEN WITHIN 5 MINS SHE LOOKED BETTER SHE WAS CONSCIUOS AND BREATHING AND COHERENT. HER FAMILY MEMBER IS A NURSE AND ASSESSED HER VITALS, PARAMEDICS WERE CALLED IN FIRST 2 MINUTES OF EVENT.THEY CHECKED HER ATABOUT 7MIN POST VACCINATION BP 96/60, THEY TOOK HER INTO THE AMBULANCE .  1 HOUR LATER I CALLED THE MOTHER THE MOTHER SAID SHE WAS FINE AND WAS GRATEFUL FOR THE CALL.  PARAMEDICA ASSESSMENT SYNCOPE AND FEAR OF NEEDLES.
my mother who also had Moderna this year is now suffering the same ill fate; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (my mother who also had Moderna this year is now suffering the same ill fate) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS], ASCORBIC ACID (VITAMIN C ACID), B COMPLEX [BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE MONONITRATE], COLLAGEN and COLECALCIFEROL (D) for an unknown indication.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (my mother who also had Moderna this year is now suffering the same ill fate). At the time of the report, ALOPECIA (my mother who also had Moderna this year is now suffering the same ill fate) outcome was unknown.
flushing right after vaccination and then dizzy, 2 hours later had HA and difficulty breathing and central chest tightness
Significant arm pain; strong chills the night of the vaccine administration.  Arm pain resolved over few days.  The effects were not alarming or significant enough to warrant medical follow up.
12/28 - 2 hours after injection - terrible arm pain. Could not raise arm and felt like a pulled muscle from my neck all the way down arm. This went on for 4 days. The pain woke me up at night for 2 nights. Just took Ibuprofen. This pain has resolved.  12/29 - body aches, chills, joint pain, fatigue, SOB on exertion, runny nose, and sneezing. These symptoms went on for 5 days. Mostly resolved - still some fatigue and SOB on exertion, runny nose, and sneezing. Again, treated with ibuprofen and rest. 1/31 - Extreme nausea, aggitatation, and fatigue. Took Zofran and went to bed at 7pm and slept until 9am. Felt much better.   1/2 - Completed a virtual visit. Advised to come in to clinic for covid test only. Not seen by physician. Negative results, and no F/U from a provider.   1/5 - All symptoms resolved except some fatigue and SOB on exertion, runny nose, and sneezing.
Red, swelling - shoulder down arm approx. 4 inches - lump - still on arm - 3 wks later.
This spontaneous report was received from a certified medical assistant and referred to a patient of unknown age (sex not reported). On 01-NOV-2013, the patient was vaccinated with the first GARDASIL (lot #, expiration date, strength, dose, frequency and route of administration were not reported) injection and on 27-NOV-2013, the patient received the second dose of GARDASIL. No adverse symptoms were reported. Additional information has been requested.
Nosebleeds, weakness, fatigue, high blood pressure, rapid heartbeat, fluctuating heartbeat to the extremes, "seizure like" episodes, dizziness, passing out, zoning out, catatonic state, numbness in legs and feet, double vision. Several ER visits and doctor visits. Tests come back ok with no explanation. Had nose cauterized. Didn't work. Blood pressure stayed elevated. This went on from 9/15/12 thru 9/26/12. Stayed in hospital for two days trying to figure out what was wrong. We are going back to doctor Monday, October 1,2012.Also...her chest and face would turn beet red before some episodes.
Per patient's mother: He had swelling of the Left deltoid injection site. He had a "sleepless" night on Monday evening (3/21/16). He stated his head hurt, his neck hurt, and he had back pain. He also felt chills. He was photosensitive on 3/22/16. He felt weak and tired. Symptoms continued through 3/23/16.
Resident not feeling well, very anxious, wants to go to hospital. All VS stable and WNL, BS 126. Family states resident has behavior like this when she has a UTI.  she does have upper airway wheezes and bilateral lower lobe crackles, oxygen increased to 3LPM and is @ 96% whereas when she was on 1LPM she was Sat @ 86%. Residents skin color is very pale, she is lethargic and complaining of nausea and fatigue at this time.  EKG done at this time per facility machine. Report reads as follows: atrial fibrillation with rapid mean ventricular response minor high-lateral and lateral repolarization disturbance, consider ischemia, LV overload or aspecific change, abnormal ECG, unconfirmed report. Dr. B returned call, requesting that EKG be uploaded into PCC, EKG was uploaded per request. Dr. B called the center and spoke to this writer, new orders to give additional one time dose of lasix 80mg now and then hold her 60mg dose of lasix in the morning and give her 80mg instead. Then resume normal dosing.
This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of adverse reaction (For 1st dose, refer case US2019GSK029971). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever, headache, nausea, pain, nerve pain, swallowing painful, chewing difficulty and speech disorder. On an unknown date, the outcome of the fever, headache, nausea, pain, nerve pain, swallowing painful, chewing difficulty and speech disorder were unknown. It was unknown if the reporter considered the fever, headache, nausea, pain, nerve pain, swallowing painful, chewing difficulty and speech disorder to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced high fever, severe headache, nausea, and severe aches and pains like the ones experienced with the flu. A few weeks later, the patient had nerve pain in maxilla (upper jaw bone) so severe that she could barely swallow without pain and had pain severe enough to prevent her from speaking or chewing food. The reporter asked if this nerve pain could be a side effect of the booster SHINGRIX (2nd dose).
Within 8 hours after receiving booster, experienced fast heart rate (95-120 bpm), weakness, headache and dizziness. Heartrate was measured continuously by my watch which kept alerting me that an abnormal heart rate was detected (normal resting heart rate is 69). Went to urgent care for EKG which was inconclusive. Then went to the hospital ER, EKG found no abnormal function, given fluids, anti-inflammatory, and observed until heartrate came down below 90.  Within 2 weeks eczema patches started growing on my face, neck, and ears for the first time ever.  The ear eczema got so bad I had to get a prescription steriod cream (Cloderm) and the ENT doctor had to clear blocked excess wax from my left ear which was blocking hearing and creating pressure.
no additional AEs; expired lot of PROQUAD was administered; This spontaneous report was received from a medical assistant and the vaccine provider referring to a 4-year-old male patient. The patient's medical history, concurrent conditions and drug reaction/allergies were not reported. Concomitant medication included sterile diluent (0.5 milliliter (mL), once, lot # W025272, expiration date: 20-JAN-2025).  On 21-MAR-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin [rHA]) (PROQUAD) injection, 0.5 milliliter (mL), once, lot #U029295, expiration date: 19-MAR-2023, administered for prophylaxis in right arm (strength and route of administration were not provided) (expired product administered). No additional adverse events.  It was reported that staff did not confirm expiration date before administration. Expiration date was discovered when entering vaccine information. Company was contacted and the reporter was informed that vaccine was still potent (2 days after expiration date). Per healthcare professional, re-vaccination was not required. The vaccine was not available for return/evaluation and was currently in provider office. The operator of vaccine was healthcare professional who had been trained. The patient was vaccinated at health clinic/hospital. The vaccine was purchased with funds. The event of expired product administered occurred in the process of preparation and administration. There was no temperature excursion occurred.
Information has been received from a registered nurse concerning a 14 year old female who on 09-AUG-2007 was vaccinated intramuscularly with the first dose of GARDASIL (0.5 ml) (lot # 658282/0929U).  Subsequently, following vaccination, the patient fainted. It was noted that the nurses are having patients lay down prior to administration of the vaccine. Unspecified medical attention was sought.  The patient subsequently recovered.  Additional information has been requested.  This is one of two reports from the same source. This is in follow-up to report (s) previously submitted on 9/17/2007.The nurse reported that the patient has had no problems since the incident. Additional information has beeb requested. This is one of two reports from the same source.
Severe chills on Sunday evening, plus body aches and headache.  Unable to work on Monday, continued chills, body aches and headache.   Moderate sweats on Monday evening.  By Tuesday late morning back to normal.
48 hours after flu mist onset with fatigue, rhinorrhea, red eyes, conjunctivitis.
"Pt had been diagnosed with COVID-19 on 3/28 with onset of cold-like symptoms several days before. He was doing better around the time of his diagnosis and then symptoms progressed in the past few days. Developed significant dyspnea with speaking, ambulating. Requiring cold flow O2."
Flat red circular rash. Each dot approximately 1cm; This is a spontaneous report from a contactable consumer (patient). A 66-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: Solution for injection; Lot Number: EN6206, Expiration Date: Unknown), via an unspecified route of administration, administered in arm left on 04Mar2021 09:45 (at the age of 66-year-old) as 2nd dose, single for covid-19 immunisation. Medical history included Anxiety, osteoarthritis, Graves' disease: (in remission). known allergies was TB test. The patient's concomitant medications were not reported. The patient took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: Solution for injection; Lot Number: EM9810, Expiration), via an unspecified route of administration, administered in arm left on 11Feb2021 02:00 for covid-19 immunisation. The patient experienced Flat red circular rash. Each dot approximately 1cm on 04Mar2021 18:00. Not itchy. Mainly on forearms. The outcome of the event was not recovered.   No follow-up attempts are Possible. No further information is expected.
After receiving the second GARDASIL shot the pt started having a hard time breathing. She tried taking BENADRYL but it continued to worsen. She had two doses of epi 1:1000 and prednisone. It improved.
Mild fever; tiredness; nausea; shingles; This is a spontaneous report from a contactable consumer (patient). This is the report regarding first dose. A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 07Apr2021 17:30 (Lot Number: 8729) at the age of 55 years, as single dose for covid-19 immunisation.  The patient medical history was not reported.  The patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received multivitamin within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Apr2021 19:00 the patient experienced mild fever, tiredness, nausea, shingles appeared on right arm. The events were non-serious with outcome of recovering.   No follow-up attempts are needed. No further information is expected.